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The Significance of Perfusion Defect at
Myocardial Perfusion MR Imaging in a
Cat Model of Acute Reperfused
Myocardial Infarction
Objective: To determine whether the size of a perfusion defect seen at
myocardial perfusion MR imaging represents the extent of irreversibly damaged
myocardium in acute reperfused myocardial infarction. 
Materials and Methods: In nine cats, reperfused myocardial infarction was
induced by occlusion of the left anterior descending coronary artery for 90 min-
utes and subsequent reperfusion for 90 minutes. At single-slice myocardial perfu-
sion MR imaging at the midventricular level using a turbo-FLASH sequence, 60
short-axis images were sequentially obtained with every heart beat after bolus
injection of gadomer-17. The size of the perfusion defect was measured and
compared with both the corresponding unstained area seen at triphenyl tetrazoli-
um chloride (TTC) staining and the hyperenhanced area seen at gadophrin-2-
enhanced MR imaging performed in the same cat six hours after myocardial per-
fusion MR imaging. 
Results: The sizes of perfusion defects seen at gadomer-17-enhanced perfu-
sion MR imaging, unstained areas at TTC staining, and hyperenhanced areas at
gadophrin-2-enhanced MR imaging were 20.4 4.3%, 29.0 9.7%, and 30.7
10.6% of the left ventricular myocardium, respectively. The perfusion defects
seen at myocardial perfusion MR imaging were significantly smaller than the
unstained areas at TTC staining and hyperenhanced areas at gadophrin-2-
enhanced MR imaging (p < .01). The sizes of both the perfusion defect at
myocardial perfusion MR imaging and the hyperenhanced area at gadophrin-2-
enhanced MR imaging correlated well with the sizes of unstained areas at TTC
staining (r = .64, p = .062 and r = .70, p = .035, respectively). 
Conclusion: In this cat model, the perfusion defect revealed by myocardial
perfusion MR imaging underestimated the true size of acute reperfused myocar-
dial infarction. The defect may represent a more severely damaged area of infarc-
tion and probably has prognostic significance.
etermination of myocardial infarction size is important for initial prognos-
tic assessment of clinical outcome, and is also a prerequisite for prediction
of the extent of salvageable myocardium around myocardial infarction.
MR imaging has been used for this purpose and is regarded as a promising approach,
providing excellent tissue contrast as well as high spatial and temporal resolution (1). 
The high signal intensity of myocardial infarction at T2-weighted MR imaging has a
linear relationship with increased water content of the myocardium (2). However, the
size of myocardial infarction at T2-weighted MR imaging has been reported as larger
than infarct size measured at triphenyl tetrazolium chloride (TTC) histochemical stain-
ing (3, 4), and the overestimation of infarct size is therefore unavoidable. 
Contrast-enhanced MR imaging of myocardial infarction may, on the other hand, re-
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Dflect different physiological information according to the
time after administration of contrast agents, e.g. early ver-
sus delayed. Early enhancement is due, in part, to the pa-
tency of the large epicardial artery and microvessels in the
myocardium, and is thought to reflect myocardial perfu-
sion (5, 6). Reports have shown that the perfusion defects
seen at myocardial perfusion MR imaging were smaller
than the hyperenhanced areas revealed by gadolinium-di-
ethylene triamine penta-acetic acid (Gd-DTPA)-enhanced
MR imaging, and correlated well with the infarcted areas
seen at TTC staining (3). Although the matter is still con-
troversial, delayed enhancement after the use of Gd-DTPA
seems to overestimate the size of myocardial infarction by
approximately 10 20% (6 8). A necrosis-avid MR con-
trast agent, bis-gadolinium mosoporphins (Gadophrin-2;
Schering, Berlin, Germany), has become available for ex-
perimental purposes and appears to have a high affinity for
necrotic tissue. The hyperenhanced areas revealed by
gadophrin-2-enhanced MR imaging correlate well with the
infarcted areas seen at TTC staining (4, 9).
Using combined MR imaging, other investigators have
recently attempted to distinguish between reversibly and
irreversibly damaged myocardium. Saeed et al. (10) sug-
gested that differences in the size of the hyperenhanced re-
gion demarcated by gadophrin-2 and Gd-DTPA might pro-
vide an estimation of salvageable myocardium. In contrast,
Rogers et al. (11) found that combined assessment of early
and delayed enhancement patterns using only Gd-DTPA
might predict late functional recovery after reperfused my-
ocardial infarction.
For accurate evaluation of viable myocardium, a stan-
dard MR imaging method depicting irreversibly damaged
myocardium should first be determined. To the best of our
knowledge, the perfusion defect seen at myocardial perfu-
sion MR imaging has not been compared with true infarct
size. The purpose of this study was, therefore, to deter-
mine whether, in acute reperfused myocardial infarction,
the perfusion defect seen at myocardial perfusion MR
imaging can be considered as irreversibly damaged my-
ocardium.
MATERIALS AND METHODS
This experimental study was approved by the institution-
al committee for animal research. In 14 adult cats, the left
anterior descending (LAD) coronary artery just distal to the
first diagonal branch was occluded for 90 minutes, prior to
reperfusion for 90 minutes. The animal preparation meth-
ods employed have previously been described in detail (9). 
For MR imaging, a 1.5-T imager (Magnetom Vision;
Siemens Medical Systems, Erlangen, Germany) with a 27-
cm-diameter circularly polarized head array coil was used.
During the procedure, heart rates were kept between 140
and 170 beats per minute, and with every beat, 60 short-
axis myocardial perfusion images were sequentially ob-
tained at the left midventricular level using an electrocar-
diograhy (ECG)-triggered turbo fast low-angle shot
(FLASH) sequence. In order to allow magnetization to
reach a steady state, five images were acquired prior to a
bolus injection of 0.05 mmol/kg of gadomer-17via the
femoral vein. The acquisition parameters for the inversion-
recovery turbo-FLASH imaging sequence were as follows:
repetition time, 2.5 msec; echo time, 1.2 msec; inversion
time, 200 msec; flip angle, 8 ; field of view, 306 350 mm;
matrix, 90 128; slice thickness, 10 mm; and acquisition
time, 45 55 seconds. At the same slice position, ECG-trig-
gered breath-hold T1-weighted turbo spin-echo images
were then obtained 60, 90, and 120 minutes after adminis-
tration of 0.025 mmol/kg of gadophrin-2, also via the
femoral vein. This enhanced imaging was performed six
hours after myocardial perfusion MR imaging and with the
following parameters: repetition time, 400 600 msec (ac-
cording to the heart rate); echo time, 30 msec (with 13
echo trains); field of view, 210 280 mm; matrix, 130
256; slice thickness, 5 mm; and acquisition time, 9 12
seconds. Since the plasma half-life of gadomer-17 is ap-
proximately 0.5 1.5 hours and the interval was thus at
least 4 5 times the half-life, six hours was regarded as
long enough to nullify the effect of previously-injected
gadomer-17. Five cats died before the completion of image
acquisition, and nine, weighing 3.5 5.1 (mean, 4.38) kg,
were therefore included in this study. 
After imaging studies were complete, the cats were sacri-
ficed. Their excised hearts were cut into five or six consec-
utive, 5-mm-thick slices in the same plane as that in which
the MR images were obtained. The specimens were then
immersed in 1.5% TTC solution at 36 for 15 minutes,
and after staining were stored in 10% formalin solution for
12 hours. The area of infarction was defined as a TTC-un-
stained area, and was used as a reference for determining
true infarct size.
In all nine cats, perfusion defects were present at the ante-
rior and septal wall of the left ventricle, and to verify this,
time-signal intensity curves were obtained at the left ven-
tricular cavity, the site of the defect, and the posterior wall
of the left ventricle (normal myocardium) (Fig. 1A). The
time-signal intensity curves demonstrated a characteristic
pattern of myocardial enhancement (Figs. 1B, C). There
was rapid wash-in and wash-out of contrast agent at normal
myocardium, but a slow wash-in and disturbed wash-out at
the perfusion defect led to a gradual increase in signal inten-
sity. We measured the size of the defect in the image in
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enhanced areas in the gadophrin-2-enhanced image which
showed maximal enhancement. This was performed manu-
ally, twice, and averaged without knowledge of the TTC
staining results. The sizes of the perfusion defects, hyperen-
hanced areas, and TTC-unstained areas were expressed as a
percentage of the corresponding left ventricular myocardial
(LVM) area, calculated by subtracting the area outlined by
the endocardial surface of the left ventricle from that out-
lined by its epicardial surface.
Using paired Student t tests, the size of the perfusion de-
fect was compared with the corresponding unstained area
seen at TTC staining and the hyperenhanced area at
gadophrin-2-enhanced MR imaging. Correlation between
the sizes of abnormal areas seen at MR (myocardial perfu-
sion and gadophrin-2-enhanced) imaging and true infarct
sizes, at TTC staining, were analyzed using Spearman’s
correlation coefficient. A p value of less than 0.05 was con-
sidered significant.
RESULTS
At both MR imaging and TTC staining, all nine cats
showed evidence of myocardial infarction in LAD territory.
Although myocardial perfusion MR imaging showed lower
spatial resolution, perfusion defects were also obvious and
measurable. The sizes of these at gadomer-17-enhanced
perfusion MR imaging, and of unstained areas at TTC stain-
ing and hyperenhanced areas at gadophrin-2-enhanced MR
imaging were 20.4 4.3%, 29.0 9.7%, and 30.7 10.6%
of the LVM area, respectively (Fig. 2). The perfusion defects
seen at myocardial perfusion MR imaging were significantly
smaller than unstained areas at TTC staining and hyperen-
hanced areas at gadophrin-2-enhanced MR imaging (p <
.01). The sizes of both the perfusion defect at myocardial
perfusion MR imaging and the hyperenhanced area at
gadophrin-2-enhanced MR imaging correlated well with the
sizes of unstained areas at TTC staining (r = .64, p = .062
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Fig. 1. Myocardial perfusion MR image and its time-signal intensity
curves derived from the left ventricular blood pool, perfusion defect,
and normal myocardium. 
A. Short-axis myocardial perfusion MR image obtained at the left
midventricular level shows a perfusion defect at its anterior wall. To
obtain time-signal intensity curves, regions of interest were placed
in the left ventricular cavity (V), perfusion defect (P), and normal
myocardium (N).
B. Time-signal intensity curve obtained from the left ventricular
blood pool of a representative case shows an initial, steep increase
in signal intensity and then a plateau, according to the first pass of
contrast agent. 
C. Time-signal intensity curve obtained from both the perfusion de-
fect and normal myocardium of a representative case demon-
strates typical myocardial enhancement for each region. The curve
derived from normal myocardium shows a rapid increase and de-
crease in signal intensity; in contrast, that derived from the perfu-
sion defect shows a slow but steady increase in signal intensity
due to disturbed wash-out of contrast agent.
AB
Cand r = .70, p = .035, respectively) (Fig. 3), though the sta-
tistical significance of this correlation was marginal.
DISCUSSION
In the present study, the perfusion defects seen at my-
ocardial perfusion MR imaging were significantly smaller
than unstained areas at TTC staining and hyperenhanced
areas at gadophrin-2-enhanced MR imaging. According to
some researchers (3, 12), however, this defect matched the
TTC-unstained area. Similar correlation was observed in
our study, though the defect was obviously smaller than the
TTC-unstained area. As far as we are aware, these results
have not been previously reported, and probably indicate
that in acute reperfused myocardial infarction, an area of
reperfused but necrotic myocardium is present. The findings
that time-signal intensity curves showed a characteristic pat-
tern of myocardial enhancement and all perfusion defects
were smaller than areas at risk served as verification of the
perfusion defect seen at myocardial perfusion MR imaging. 
This defect may represent the area where the microvas-
culature was occluded, and has therefore been described as
a “no reflow phenomenon” (13, 14). The defect might not
simply be an area of irreversibly injured myocardium, but
may represent greater myocardial damage. This assump-
tion is supported by the finding that all perfusion defects in
our study were located in the central or endocardial por-
tion of acute reperfused myocardial infarction. Previous
studies also indicated that the presence of the perfusion de-
fect at MR imaging correlated with poorer global ventricu-
lar function during the early post-infarction phase (15) and
indicated that more frequent long-term cardiovascular
complications would arise (16). Moreover, the defect re-
mained a strong prognostic marker even after control of in-
farct size (16). Like infarct size, the size (as well as the
presence) of perfusion defect is prognostically significant.
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Fig. 3. Correlation between the sizes of abnormal areas at MR (myocardial perfusion and gadophrin-2-enhanced) imaging and true in-
farct sizes at TTC staining. Spearman’s correlation coefficients (r) were 0.64 (A) between myocardial perfusion MR imaging and TTC
staining and 0.70 (B) between gadophrin-2-enhanced MR imaging and TTC staining. 
AB
Fig. 2. Comparison of the size of perfusion defects at myocardial
perfusion MR imaging (20.4 4.3% of the area of the left ventric-
ular myocardium [LVM]), hyperenhanced areas at gadophrin-2-
enhanced MR imaging (30.7 10.6%), and unstained areas at
TTC staining (*) (29.0 9.7%). The first mentioned was signifi-
cantly smaller than the second and last (p < .01). Because we used gadomer-17, an intermediate-sized con-
trast agent which acts like a blood pool contrast agent dur-
ing the first pass, the perfusion defect could be more accu-
rately delineated in this study than where Gd-DTPA was
used. A blood pool contrast agent limits contrast agent dif-
fusion through the endothelial membrane (17).
Although little is known about the mechanism of
gadophrin-2 accumulation in necrotic tissue, initial studies
showed that gadophrin-2 has a peculiar affinity for necrotic
tissue (18, 19). In experimental studies involving reperfused
myocardial infarction, gadophrin-2-enhanced MR imaging
accurately indicated the extent of irreversibly damaged my-
ocardium, showing strong and persistent hyperenhance-
ment (4, 9). Our results, in which the extent of hyperen-
hanced areas at gadophrin-2-enhanced imaging was some-
what similar to that of unstained areas at TTC staining,
were in accordance with those obtained previously.
Correlation between the findings of MR imaging and
TTC staining in our study was relatively weak compared
with that of earlier reports (4, 9), and this may be because
we did not analyze the whole LVM but only a single slice.
Previous studies found that the limits of agreement be-
tween MR imaging- and TTC-based measurements of in-
farct size were wider in single-slice comparison than in
whole-LVM comparison (4). In addition, some change in
slice position and anatomical distortion is inevitable when
preparing heart specimens for TTC staining. 
The present study suffers certain limitations. First, fol-
low-up was not performed after acute myocardial infarc-
tion, and functional recovery in reperfused myocardial in-
farction could thus not be evaluated. We do, however, fo-
cus on measurement of the perfusion defect at myocardial
perfusion MR imaging during the acute stage. Second, the
difference in slice thickness (myocardial perfusion MR
imaging: 10mm; gadophrin-2-enhanced MRI: 5 mm; and
TTC-stained specimen: surface) could affect the precision
of the match. Compared to heart specimens, MR imaging
could overestimate infarct sizes due to the partial-volume
effect. Because the infarct sizes we encountered are consid-
ered sufficiently large, this concern may, however, be triv-
ial. In small infarctions, on the other hand, infarct sizes can
be greatly affected by slice thickness and the partial-vol-
ume effect.
In conclusion, a perfusion defect seen at myocardial per-
fusion MR imaging underestimates the true size of acute
reperfused myocardial infarction in a cat model. It may
represent a more severely damaged area of infarction and
is probably prognostically significant. 
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